Several clinical studies have shown that florzolotau can bind to 3R, 4R, or mixed 3R and 4R tau isoforms in diverse tauopathies, including AD, PSP, and CBD, as well as FTD due to MAPT mutations.81, 96. This evidence concerns the gene MAPT and frontotemporal dementia.